CHARTWELL INVESTMENT PARTNERS, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 172 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,443,000
+7.7%
24,231
+23.4%
0.04%
+15.4%
Q2 2021$1,340,000
-0.7%
19,643
+1.0%
0.04%
-2.5%
Q1 2021$1,350,000
-14.3%
19,456
-5.1%
0.04%
-20.0%
Q4 2020$1,575,000
-16.3%
20,501
-18.5%
0.05%
-27.5%
Q3 2020$1,881,000
+18.8%
25,1450.0%0.07%
+13.1%
Q2 2020$1,583,000
+9.9%
25,145
-26.7%
0.06%
-10.3%
Q1 2020$1,441,000
+4.5%
34,314
+13.0%
0.07%
+47.8%
Q4 2019$1,379,000
-49.9%
30,363
-49.5%
0.05%
-50.0%
Q3 2019$2,752,000
-22.0%
60,1370.0%0.09%
-20.0%
Q2 2019$3,526,000
+39.1%
60,137
+6.4%
0.12%
+40.2%
Q1 2019$2,534,000
+16.7%
56,533
+1.4%
0.08%
+7.9%
Q4 2018$2,172,000
-42.3%
55,767
-31.9%
0.08%
-31.5%
Q3 2018$3,766,000
+5.7%
81,839
+0.1%
0.11%
+4.7%
Q2 2018$3,563,000
+6.2%
81,725
-3.8%
0.11%
-7.8%
Q1 2018$3,356,00084,9700.12%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Prosight Management, LP 164,300$9,633,0004.86%
Atika Capital Management LLC 230,000$13,485,0002.65%
DAFNA Capital Management LLC 93,942$5,508,0002.07%
PFM Health Sciences, LP 1,828,378$107,198,0002.04%
Perceptive Advisors 1,380,171$80,919,0001.86%
Eversept Partners, LP 73,501$4,309,3641.21%
Partner Investment Management, L.P. 18,159$1,065,0001.13%
Rhenman & Partners Asset Management AB 170,000$9,967,0001.10%
EMERALD ADVISERS, LLC 425,510$24,948,0001.00%
EMERALD MUTUAL FUND ADVISERS TRUST 388,418$22,773,0000.90%
View complete list of ARENA PHARMACEUTICALS INC shareholders